These results suggest that the pro-oncogenic properties of TAZ-AS202 are at least in part mediated by modulation of the protein level of the transcription factor E2F1 that in turn regulates the expression of EPHB2 and possibly other effectors, leading to increased cancer cells aggressiveness. The gene discussed is EPHB2; the disease is cancer.